Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Sequential Administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of Mitomycin C (MMC) for the Treatment of High-Grade Nonmuscle Invasive Bladder Cancer After BCG FailureUrol. Oncol 2020 Jul 22;[EPub Ahead of Print], T Juvet, A Mari, K Lajkosz, CJ Wallis, C Kuk, A Erlich, L Krimus, NE Fleshner, GS Kulkarni, AR Zlotta
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.